查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935527

全球顱內支架市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Intracranial Stents Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計顱內支架市場規模將從 2025 年的 30.9 億美元成長到 2034 年的 51.2 億美元，2026 年至 2034 年的複合年成長率為 5.78%。

由於腦血管疾病（例如動脈瘤和狹窄）的發生率不斷上升，顱內支架市場正經歷顯著成長。隨著世界人口老化和影響腦部血流的疾病發生率增加，對有效治療方法的需求也日益成長。顱內支架透過支撐血管和改善血流，成為治療這些疾病的重要工具。支架設計的創新，包括生物可吸收支架和藥物釋放型支架的研發，提高了這些器械的療效和安全性，使其成為醫療機構和患者更具吸引力的選擇。

此外，微創技術的進步正在改變顱內支架市場。血管內手術的廣泛應用，使得支架可以透過微小切口植入，從而縮短了患者的恢復時間，並改善了治療效果。隨著醫療專業人員積極採用這些技術，對即使在解剖結構複雜的情況下也能有效植入的先進顱內支架的需求預計將會增加。此外，術中血管造影術和3D成像等影像技術的整合提高了支架植入的精確度，進一步推動了市場成長。

此外，神經病學領域研發投入的不斷增加正在推動顱內支架市場的創新。學術機構、研究組織和醫療設備製造商之間的合作正在推動新一代支架的研發，以應對當前挑戰並改善患者照護。人們對腦血管疾病的認知不斷提高，以及對早期療育重要性的理解，也促進了市場的擴張。總之，顱內支架市場預計將迎來強勁成長，其特點是技術進步、注重微創手術以及致力於改善腦血管疾病患者的治療效果。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球顱內支架市場（依產品類型分類）

  • 市場分析、洞察與預測
  • 自動擴張型支架
  • 球囊擴張支架
  • 支架輔助彈簧圈栓塞術

5. 全球顱內支架市場（依適應症分類）

  • 市場分析、洞察與預測
  • 顱內狹窄
  • 腦動脈瘤

6. 全球顱內支架市場（依最終用戶分類）

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他

7. 全球顱內支架市場（依地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Penumbra Inc
    • Medtronic
    • Stryker Corporation
    • Boston Scientific Corporation
    • Johnson & Johnson Services Inc
    • Cook Medical
    • Acandis
    • Penumbra, Inc
    • MicroPort Scientific
    • Phenox
    • Terumo Corporation
簡介目錄
Product Code: VMR11211229

The Intracranial Stents Market size is expected to reach USD 5.12 Billion in 2034 from USD 3.09 Billion (2025) growing at a CAGR of 5.78% during 2026-2034.

The intracranial stents market is experiencing significant growth, driven by the increasing prevalence of cerebrovascular diseases, such as aneurysms and stenosis. As the global population ages and the incidence of conditions that affect blood flow to the brain rises, the demand for effective treatment options is surging. Intracranial stents are essential tools in the management of these conditions, providing support to blood vessels and improving blood flow. Innovations in stent design, including the development of bioresorbable and drug-eluting stents, are enhancing the efficacy and safety of these devices, making them more appealing to healthcare providers and patients alike.

Moreover, advancements in minimally invasive techniques are transforming the intracranial stents market. The rise of endovascular procedures, which allow for the placement of stents through small incisions, is reducing recovery times and improving patient outcomes. As healthcare providers increasingly adopt these techniques, the demand for advanced intracranial stents that can be deployed effectively in challenging anatomical locations is expected to grow. Additionally, the integration of imaging technologies, such as intraoperative angiography and 3D imaging, is enhancing the precision of stent placement, further driving market growth.

Furthermore, the increasing focus on research and development in the field of neurology is fostering innovation in the intracranial stents market. Collaborations between academic institutions, research organizations, and medical device manufacturers are leading to the development of next-generation stents that address current limitations and improve patient care. The growing awareness of cerebrovascular diseases and the importance of early intervention is also contributing to the expansion of the market. In summary, the intracranial stents market is set for robust growth, characterized by technological advancements, a focus on minimally invasive procedures, and a commitment to improving patient outcomes in the management of cerebrovascular conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Self-Expanding Stents
  • Balloon Expanding Stents
  • Stent-Assisted Coil Embolization

By Disease Indication

  • Intracranial Stenosis
  • Brain Aneurysm

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Penumbra Inc, Medtronic, Stryker Corporation, Boston Scientific Corporation, Johnson Johnson Services Inc, Cook Medical, Acandis, Penumbra, Inc, MicroPort Scientific, Phenox, Terumo Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRACRANIAL STENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Self-Expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Balloon Expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Stent-Assisted Coil Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRACRANIAL STENTS MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Disease Indication
  • 5.2. Intracranial Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Brain Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRACRANIAL STENTS MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTRACRANIAL STENTS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Disease Indication
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Disease Indication
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Disease Indication
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Disease Indication
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Disease Indication
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INTRACRANIAL STENTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Penumbra Inc
    • 9.2.2 Medtronic
    • 9.2.3 Stryker Corporation
    • 9.2.4 Boston Scientific Corporation
    • 9.2.5 Johnson & Johnson Services Inc
    • 9.2.6 Cook Medical
    • 9.2.7 Acandis
    • 9.2.8 Penumbra, Inc
    • 9.2.9 MicroPort Scientific
    • 9.2.10 Phenox
    • 9.2.11 Terumo Corporation